Navigation Links
Maxam Nutraceutics Introduces PCA-Rx as a Natural Chelation Alternative for Autism Spectrum Disorder Treatment

HOOD RIVER, Ore., May 27 /PRNewswire/ -- According to the Center for Disease Control (CDC), autism has risen to an epidemic rate of 1 in 100 in the U.S., up from 1 in 150 in 2007. While controversy looms regarding its cause, many parents of autistic children believe a correlation exists with toxin accumulation. To give autism spectrum disorder (ASD) sufferers a natural alternative to chelation therapy, Maxam Nutraceutics ( has introduced PCA-Rx.

While chelation is commonly administered intravenously using the drug agents dimercaptosuccine acid (DMSA) and dimercaptopropane sulfonate (DMPS), this heavy metal removal method has come increasingly under fire by parents concerned about side effects.

Tina Beeck, who switched from chelation to PCA-Rx for treating her 4-year-old autistic son, Miller, stated, "We have been extremely pleased with PCA-Rx. We have seen tremendous cognitive gains – slowly at first and then dramatically. Sometimes he seems downright neuro-typical."

The result of years of rigorous research and development, PCA-Rx represents a breakthrough in toxin removal technology called Clathration Therapy. PCA-Rx is an epigenetic cell fermentation formula comprised of helpful bacteria and other microbes that, when used, become a natural, living part of the body's immune system. Administered orally, one to eight sprays per day under the tongue, it envelops, neutralizes and removes the harmful toxins through stool, urine, skin and breath, without ever touching vital organs or tissue.

PCA-Rx helps to eliminate heavy metals, chemical toxins and harmful parasite microorganisms; reduce cardio and cerebral vascular plaque; lower elevated enzyme counts; and decrease environmental illness effects.

"PCA-Rx represents the next generation of chelation technology," explained Maxam Nutraceutics President James Cole. "We're thrilled to provide autism sufferers a natural toxin removal treatment that's easy-to-use, powerful and with no known side effects."

PCA Rx is also used for Alzheimer's, candida, cervical dystonia, chemical exposure, heart disease, hepatitis, herpes, Lyme disease, paralysis, Niemann-Pick disease and uterine fibroids. It is available through

For more information, or interview scheduling with James Cole, contact Renee Cooper, ChristieCommunications( or (805)969-3744,

*PCA Rx has not been evaluated by the FDA and not intended to diagnose, treat, or cure any disease.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bioenergy Introduces Corvalen M(R) as a Natural Treatment Option for Fibromyalgia Symptoms
2. Bersin & Associates Introduces New Talent Management Framework
3. Varian Medical Systems Introduces ProBeam(TM) Proton Therapy Platform at Particle Therapy Co-operative Group (PT COG) 2010 Meeting
4. Ambry Genetics Introduces AmbryScreen(TM), a Genetic Test Screening for Some of the Most Common and Severe Genetic Disorders Affecting Newborns.
5. Ethicon Endo-Surgery Introduces Two New Staplers for Open Surgical Procedures at ASCRS
6. Biosense Webster Introduces the THERMOCOOL(R) SF Irrigated Catheter in the European Union
7. Ethicon Endo-Surgery Introduces HARMONIC FOCUS(R) Long Curved Shears for Deep Surgical Access
8. MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients
9. Burton Medical Introduces the AIM-200(R) as a Versatile, Long-Lasting Light Source for Ambulatory Surgical Centers
10. Sikorsky Global Helicopters Introduces State-of-the-Art Emergency Medical Services Interior for S-76(R) Helicopter
11. Samplify Introduces New Compression Technology to Lower Costs for Mobile Operators Migrating to 4G
Post Your Comments:
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
Breaking Medicine News(10 mins):